544759 — Goldline Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapContrarian

Annual balance sheet for Goldline Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	—	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.542	7.9	12.4	5.92
Net Total Accounts Receivable
Net Total Receivables	111	110	138	181
Total Inventory
Total Other Current Assets
Total Current Assets	168	195	233	260
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24.7	33.6	28.4	26.5
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	194	229	262	289
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	90	102	118	121
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	135	151	159	146
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	58.9	78.6	103	142
Total Liabilities & Shareholders' Equity	194	229	262	289
Total Common Shares Outstanding